HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard G Pestell Selected Research

Caveolin 1

5/2013Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide.
7/2012Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.
5/2012Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.
1/2012Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms.
12/2011Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
12/2011Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
11/2011Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.
7/2011Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
6/2011Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.
6/2011Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard G Pestell Research Topics

Disease

179Neoplasms (Cancer)
01/2022 - 04/2002
108Breast Neoplasms (Breast Cancer)
01/2021 - 01/2002
46Carcinogenesis
01/2021 - 01/2002
43Neoplasm Metastasis (Metastasis)
01/2022 - 05/2003
31Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2002
9Inflammation (Inflammations)
12/2012 - 02/2003
8Hypoxia (Hypoxemia)
12/2015 - 04/2010
8Mitochondrial Diseases (Mitochondrial Disease)
05/2013 - 04/2010
7Hyperplasia
11/2006 - 10/2002
6Infections
01/2020 - 05/2003
6Colonic Neoplasms (Colon Cancer)
11/2019 - 03/2004
5Adenocarcinoma
06/2015 - 07/2003
5Chromosomal Instability (Chromosome Stability)
04/2015 - 03/2012
5Carcinoma (Carcinomatosis)
11/2009 - 07/2002
4Glioblastoma (Glioblastoma Multiforme)
04/2021 - 05/2013
4Lymphatic Metastasis
04/2012 - 08/2010
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2021 - 03/2004
3Triple Negative Breast Neoplasms
11/2019 - 06/2013
3Retinoblastoma (Glioblastoma, Retinal)
01/2019 - 09/2008
3Hypertrophy
05/2013 - 08/2008
3Starvation
10/2012 - 08/2011
3Melanoma (Melanoma, Malignant)
05/2012 - 12/2004
3Noninfiltrating Intraductal Carcinoma (DCIS)
06/2010 - 04/2009
3Colorectal Neoplasms (Colorectal Cancer)
07/2008 - 01/2002
3Ovarian Neoplasms (Ovarian Cancer)
09/2006 - 05/2003
2Pathologic Processes
01/2020 - 01/2015

Drug/Important Bio-Agent (IBA)

69Cyclin D1IBA
01/2020 - 04/2002
42Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2002
36Caveolin 1IBA
05/2013 - 10/2002
22Lactic Acid (Lactate)FDA LinkGeneric
08/2013 - 06/2010
18DNA (Deoxyribonucleic Acid)IBA
01/2021 - 05/2003
18CyclinsIBA
01/2020 - 04/2002
18Biomarkers (Surrogate Marker)IBA
06/2018 - 06/2009
15MicroRNAs (MicroRNA)IBA
01/2022 - 08/2008
12Hormones (Hormone)IBA
01/2021 - 10/2003
12TamoxifenFDA LinkGeneric
05/2014 - 08/2008
12KetonesIBA
05/2013 - 09/2010
10Phenobarbital (Luminal)FDA Link
01/2021 - 01/2006
10Transcription Factors (Transcription Factor)IBA
07/2013 - 11/2002
10beta CateninIBA
11/2011 - 01/2002
9Pharmaceutical PreparationsIBA
01/2022 - 07/2008
9LigandsIBA
04/2021 - 04/2004
9Androgen Receptors (Androgen Receptor)IBA
01/2021 - 12/2003
9Messenger RNA (mRNA)IBA
09/2019 - 01/2004
8CytokinesIBA
11/2019 - 06/2002
8Estrogen ReceptorsIBA
06/2018 - 01/2002
8NF-kappa B (NF-kB)IBA
08/2012 - 02/2003
8AntioxidantsIBA
06/2012 - 09/2010
7Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 - 07/2002
7CarcinogensIBA
05/2013 - 10/2003
7Glutamine (L-Glutamine)FDA Link
05/2013 - 09/2010
7Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2012 - 08/2011
7Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2011 - 05/2003
6EnzymesIBA
10/2018 - 12/2003
6AndrogensIBA
09/2016 - 11/2006
6Phosphotransferases (Kinase)IBA
04/2015 - 07/2002
6Estrogens (Estrogen)FDA Link
09/2013 - 10/2003
6Adenosine Triphosphate (ATP)IBA
12/2011 - 08/2002
5MaravirocFDA Link
06/2020 - 08/2012
5ErbB Receptors (EGF Receptor)IBA
06/2018 - 06/2003
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018 - 05/2003
5RNA (Ribonucleic Acid)IBA
01/2017 - 10/2004
5Glucose (Dextrose)FDA LinkGeneric
12/2011 - 02/2005
5PPAR gammaIBA
12/2009 - 04/2004
5Estrogen Receptor alphaIBA
07/2009 - 09/2004
4Biological ProductsIBA
04/2021 - 11/2010
4Chemokine CCL5IBA
04/2021 - 08/2012
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2021 - 11/2019
4CCR5 Receptors (CCR5 Receptor)IBA
06/2020 - 08/2012
4ChemokinesIBA
10/2018 - 12/2006
4Antineoplastic Agents (Antineoplastics)IBA
05/2018 - 01/2007
4Sirtuin 1IBA
01/2015 - 11/2006
4Metformin (Glucophage)FDA LinkGeneric
12/2011 - 04/2011
4Small Interfering RNA (siRNA)IBA
01/2011 - 08/2008
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2011 - 09/2004
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2007 - 11/2006
3Piwi-Interacting RNAIBA
01/2021 - 03/2012
3leronlimabIBA
01/2021 - 10/2019
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 03/2005
3AgarIBA
02/2016 - 12/2003
3HoloenzymesIBA
09/2013 - 09/2008
3Cyclin-Dependent Kinase Inhibitor p16IBA
10/2012 - 06/2003
3PoisonsIBA
12/2011 - 04/2011
3Chloroquine (Aralen)FDA LinkGeneric
11/2010 - 06/2010
3Extracellular Matrix ProteinsIBA
06/2010 - 09/2003
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2009 - 09/2004
3TCF Transcription FactorsIBA
04/2006 - 01/2002
3JNK Mitogen-Activated Protein KinasesIBA
03/2005 - 05/2003
3p38 Mitogen-Activated Protein KinasesIBA
01/2005 - 05/2003
2Monoclonal AntibodiesIBA
01/2021 - 11/2019
2vicrivirocIBA
10/2019 - 08/2012
2UbiquitinIBA
09/2019 - 01/2019
2Cyclin DIBA
01/2019 - 11/2002
2Progesterone Receptors (Progesterone Receptor)IBA
06/2018 - 01/2006
2VimentinIBA
06/2018 - 07/2012
2palbociclibIBA
01/2017 - 10/2012
2src-Family KinasesIBA
11/2016 - 12/2014

Therapy/Procedure

44Therapeutics
04/2021 - 07/2002
12Drug Therapy (Chemotherapy)
01/2022 - 06/2003
5Radiotherapy
02/2016 - 01/2011